ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2025

Once-Weekly Semaglutide Versus Sodium-Glucose Co-transporter 2 Inhibitors: Real-World Impact on Weight, HbA1c, and Healthcare Resource Utilization in Type 2 Diabetes (PAUSE).

James Amamoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.